Sun M - Search Results

1

Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database.

Cheng Q, Wu Y, Yao Z, Ouyang M, Zou S, Shi X, Zhao Y, Sun M. Cheng Q, et al. Among authors: sun m. Thromb J. 2024 Aug 23;22(1):78. doi: 10.1186/s12959-024-00641-4. Thromb J. 2024. PMID: 39180077 Free PMC article.

2

Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis.

Zou SP, Cheng Q, Feng CY, Xu C, Sun MH. Zou SP, et al. World J Clin Cases. 2022 Dec 16;10(35):12959-12970. doi: 10.12998/wjcc.v10.i35.12959. World J Clin Cases. 2022. PMID: 36569016 Free PMC article.

3

Effect of ertugliflozin on renal function and cardiovascular outcomes in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

Cheng Q, Zou S, Feng C, Xu C, Zhao Y, Shi X, Sun M. Cheng Q, et al. Among authors: sun m. Medicine (Baltimore). 2023 Mar 10;102(10):e33198. doi: 10.1097/MD.0000000000033198. Medicine (Baltimore). 2023. PMID: 36897734 Free PMC article.

4

Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS).

Zou SP, Yang HY, Ouyang M, Cheng Q, Shi X, Sun MH. Zou SP, et al. Among authors: sun mh. Expert Opin Drug Saf. 2024 Mar;23(3):353-362. doi: 10.1080/14740338.2023.2251382. Epub 2023 Aug 29. Expert Opin Drug Saf. 2024. PMID: 37610085

5

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS).

Zou SP, Yang HY, Ouyang ML, Cheng Q, Shi X, Sun MH. Zou SP, et al. BMC Pharmacol Toxicol. 2023 Nov 13;24(1):62. doi: 10.1186/s40360-023-00702-w. BMC Pharmacol Toxicol. 2023. PMID: 37957717 Free PMC article.

6

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis.

Ouyang ML, Zou SP, Cheng Q, Shi X, Zhao YZ, Sun MH. Ouyang ML, et al. Front Pharmacol. 2023 Dec 13;14:1269125. doi: 10.3389/fphar.2023.1269125. eCollection 2023. Front Pharmacol. 2023. PMID: 38192408 Free PMC article.

7

Post-marketing safety concerns with palbociclib: a disproportionality analysis of the FDA adverse event reporting system.

Cheng Q, Shi X, Zhao Y, Zou S, Sun M. Cheng Q, et al. Among authors: sun m. Expert Opin Drug Saf. 2024 May;23(5):637-648. doi: 10.1080/14740338.2024.2338247. Epub 2024 Apr 12. Expert Opin Drug Saf. 2024. PMID: 38564277

8

Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis.

Ouyang M, Zou S, Cheng Q, Shi X, Zhao Y, Sun M. Ouyang M, et al. Among authors: sun m. Pharmaceuticals (Basel). 2024 May 28;17(6):698. doi: 10.3390/ph17060698. Pharmaceuticals (Basel). 2024. PMID: 38931366 Free PMC article. Review.

9

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases.

Zou S, Ouyang M, Zhao Y, Cheng Q, Shi X, Sun M. Zou S, et al. Among authors: sun m. Front Pharmacol. 2024 Jul 4;15:1392914. doi: 10.3389/fphar.2024.1392914. eCollection 2024. Front Pharmacol. 2024. PMID: 39027335 Free PMC article.

10

IL-6R Inhibitors and Gastrointestinal Perforations: A Pharmacovigilance Study and a Predicting Nomogram.

Zou S, Ouyang M, Cheng Q, Shi X, Zhao Y, Sun M. Zou S, et al. Among authors: sun m. Biomedicines. 2024 Dec 17;12(12):2860. doi: 10.3390/biomedicines12122860. Biomedicines. 2024. PMID: 39767766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,193 results

Search Page

Filters